| Bioactivity | TREM-1 inhibitory peptide GF9 (Human TREM-1(213-221)) is a ligand‐independent TREM‐1 inhibitory nonapeptide GF9 that can blunt excessive inflammation caused by rheumatoid arthritis (RA)[1]. |
| Name | TREM-1 inhibitory peptide GF9 |
| CAS | 1289375-12-7 |
| Sequence | Gly-Phe-Leu-Ser-Lys-Ser-Leu-Val-Phe |
| Shortening | GFLSKSLVF |
| Formula | C49H76N10O12 |
| Molar Mass | 997.19 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zu T Shen, et al. Rationally designed ligand-independent peptide inhibitors of TREM-1 ameliorate collagen-induced arthritis. J Cell Mol Med. 2017 Oct;21(10):2524-2534. |
TREM-1 inhibitory peptide GF9
CAS: 1289375-12-7 F: C49H76N10O12 W: 997.19
TREM-1 inhibitory peptide GF9 (Human TREM-1(213-221)) is a ligand‐independent TREM‐1 inhibitory nonapeptide GF9 that c
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.